Page last updated: 2024-10-31

ethylmaleimide and Alzheimer Disease

ethylmaleimide has been researched along with Alzheimer Disease in 2 studies

Ethylmaleimide: A sulfhydryl reagent that is widely used in experimental biochemical studies.

Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
PiƱero, DJ1
Hu, J1
Connor, JR1
Narindrasorasak, S1
Lowery, DE1
Altman, RA1
Gonzalez-DeWhitt, PA1
Greenberg, BD1
Kisilevsky, R1

Other Studies

2 other studies available for ethylmaleimide and Alzheimer Disease

ArticleYear
Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer's diseased brains.
    Cellular and molecular biology (Noisy-le-Grand, France), 2000, Volume: 46, Issue:4

    Topics: Alzheimer Disease; Astrocytoma; Blotting, Western; Brain; Brain Neoplasms; Cytoplasm; Diamide; Elect

2000
Characterization of high affinity binding between laminin and Alzheimer's disease amyloid precursor proteins.
    Laboratory investigation; a journal of technical methods and pathology, 1992, Volume: 67, Issue:5

    Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Binding, Competitive; Cations, Divalent; Chloride

1992